Oxidative stress and inflammatory bowel disease

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 4, 2012, Pages 1335-1344

  Almenier, Hazem A ^a   Al Menshawy, Hazem H ^a   Maher, Maha M ^a   Al Gamal, Salah ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Inflammatory Bowel Disease; Oxidative Stress; Pathogenesis; Review

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; FREE RADICAL; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 2; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE ACTIVITY; DISEASE COURSE; DIZYGOTIC TWINS; ENTERITIS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HYGIENE HYPOTHESIS; ILEITIS; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE FLORA; LISTERIA MONOCYTOGENES; MAJOR HISTOCOMPATIBILITY COMPLEX; MENTAL STRESS; MONOZYGOTIC TWINS; MUCOSAL IMMUNITY; MYCOBACTERIUM AVIUM; NONHUMAN; NUTRITIONAL SUPPORT; ONSET AGE; OXIDATIVE STRESS; PASSIVE SMOKING; PATHOGENESIS; PHAGOCYTE; SMOKING; SMOKING CESSATION; ULCERATIVE COLITIS; GENETICS; METABOLISM; PATHOLOGY; REVIEW;

FREE RADICALS; HUMANS; INFLAMMATORY BOWEL DISEASES; OXIDATIVE STRESS;

EID: 84860872777     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Chinyu Su and Lichtenstein GR: Epidemiology of inflammatory bowel disease. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease 8; 109:2499-2500 (2006)
2. Assche GV, Vermeire S and Rutgeerts P: Focus on Mechanisms of Inflammation in Inflammatory Bowel Disease Sites of Inhibition: Current and Future Therapies. Gastroenterology Clinics 35; 4 (2006)
3. Orholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO: Concordance of inflammatory bowel disease among Danish twins: Results of a nationwide study. Scand J Gastroenterology 35:1075 (2000)
4. Heuschen UA, Hinz U, Allemeyer EH, Stem J, Lucas M, Autschbach F, Herfath C, Heuschen G: Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology; 120(4):841-7(2001) (Pubitemid 32193181)
5. Stenson WF: Genetics of inflammatory bowel disease. Goldman: Cecil Medicine; 23rd ed.; Chapter 144(2007)
6. Chinyu Su and Lichtenstein GR: Inflammatory bowel disease. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease 8; 108, 109:2459-2538(2006)
7. Strober W, Fuss I and Mannon P: The fundamental basis of inflammatory bowel disease, Science in Medicine The Journal of Clinical Investigation 117: 514-521(2007) (Pubitemid 46348505)
8. Hanauer SB: Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Therapeutic opportunities. Inflamm Bowel Dis 1: s3-9(2006) (Pubitemid 43068428)
9. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S: Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36:476-80 (2004) (Pubitemid 38620031)
10. Mamula P, Markowitz JE, Baldassano RN: Pediatric Inflammatory Bowel Disease, cytokines and Inflammatory Bowel Disease 3; 59-69 (2008)
11. Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Belaiche J, Fiasse R, Dupas JL, Lerebours E, Piotte S, Cortot A, Vermeire S, Grandbastien B, Colombel JF: Inflammatory bowel disease in spouses and their offspring. Gastroenterology 120:816-9 (2001) (Pubitemid 32193177)
12. Lashner BA and Loftus JE: true or false? The hygiene hypothesis for Crohn's disease. American Journal of Gastroenterology 101:1003-4 (2006)
13. Amre DK, Larnbrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG: Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case control study. American Journal of Gastroenterology 101:1005-11(2006)
14. Bemstein CN, Rawsthorne P, Cheang M and Blanchard JF: A population based case control study of potential risk factors for IBD. American Journal of Gastroenterology 101:993-1002(2006) (Pubitemid 43725312)
15. Garcfa RLA, Ruigomez A and Panes J: Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130:1588-94 (2006) (Pubitemid 43668828)
16. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O: Inflammatory bowel disease: Re-evaluation of the diagnosis in a prospective population-based study in southeastern Norway. Gut 40:328 -32(1997) (Pubitemid 27145644)
17. William J, Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, Deventer SV, Goldblum R, Despain D, Hogge GS, D.V.M., Rutgeerts P: Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med ; 353:1912-25 (2005) (Pubitemid 41565956)
18. Saeed S and Kugathasan S: Epidemiology of Pediatric Inflammatory Bowel Disease, Pediatric Inflamm Bowel Dis 4; 83:102 (2008)
19. Ellingson JL, Anderson JL, Koziczkowski JJ, Radcliff RP, Sloan SJ, Allen SE and Sullivan NM: Detection of viable Mycobacterium avium subsp. paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. J Food Prot 68:966-72 (2005) (Pubitemid 40641219)
20. Ghosh S, Armitage E, Wilson D, Minor PD and Afzal MA: Detection of persistent measles virus infection in Crohn disease: current status of experimental work. Gut 48:748-52 (2006) (Pubitemid 32476968)
21. Katz JA: Prevention is the best defense: Probiotic prophylaxis of pouchitis. Gastroenterology 124:1535-8 (2003)
22. Lakatos PL, Szamosi T and Lakatos L: Smoking in inflammatory bowel diseases: Good, bad or ugly? World Journal of Gastroenterology 14; 13(46):6134-9 (2007)
23. Rubin DT and Hanauer SB: Smoking and inflammatory bowel disease. European Journal of Gastroenterology Hepatology 12:855-62 (2000) (Pubitemid 30663897)
24. Riddell RH, Kirsner JB and Shorter RG: Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB, ed. Inflamm Bowel Dis 427 (2000)
25. Stadnicki A and Colman RW: Experimental models of inflammatory bowel disease. Arch Immunol.Ther. Exp (Warsz) 51:149-55(2003) (Pubitemid 36828177)
26. Drossman DA and Ringel Y: Psychosocial factors in ulcerative colitis and Crohn's disease. In: Sartor RB, Sandborn WJ, ed. Kirsner's Inflammatory Bowel Diseases, 6th ed. Philadelphia: WB Saunders 340 (2004)
27. Kirsner JB, Shorter RG.: Recent developments in "nonspecific" inflammatory bowel disease (first of two parts) N Engl J Med;306:775-85(1982) (Pubitemid 12140925)
28. Fantone JC, Ward PA.: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:395-418 (1982)
29. Flohe L, Beckmann R, Giertz H.: Oxygen-centered free radicals as mediators of inflammation. In: Sies H, editor. Oxidative stress. London: Academic Press 403-36 (2006)
30. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman Gs, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE.: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41: 2078-86 (1996) (Pubitemid 26366811)
31. Rhian MT: Reactive oxygen species, Vascular Oxidative Stress, and Redox Signaling in Hypertension American Heart Association, Inc.44:248-252 (2004)
32. Radhika D, John T, Hancock, Steven JN:Oxidative stress signaling. Diabetes Metab Res Rev;4: 121 -149 (2003)
33. Medina S, Martinez M, Hernanz A: Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumour necrosis factor alpha, dopamine and beta- amyloid peptide 1-42. Free Radic Res 36:1179-84 (2002) (Pubitemid 35230238)
34. Dickinson1 PJ, Carrington AL, Frost GS, Boulton AJM: Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev18:260-272 (2002)
35. Gutteridge C: Lipid peroxidation and antioxidants as biomarker of tissue damage. Clin. Chem 41(12):1918-28 (1995)
36. Soloway RD and Weinmman SA: Oxidative stress as a cause of biliary lithiasis. New possibilities for medical therapy of stones or a false alarm. Hepatology 32(3):670-1(2000)
37. Vincent AM and Feldman EL: New Insights Into The Mechanisms of Diabetic Neuropathy. Reviews in Endocrine & Metabolic Disorders 5:227-236 (2004) (Pubitemid 38903580)
38. Tepel M, Echelmeyer M, Orie NN, Ziedek W: Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of haemodialysis. Kidney Int 58:2,867-72 (2000)
39. Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS: Chemiluminescence assay of mucosal active oxygen metabolites in inflammatory bowel disease. Gastroenterology 103:186-96 (1992)
40. Grisham MB: Effect of 5-aminosalicylic acid on ferrous sulfate-mediated damage to deoxyribose. Biochem Pharmacol 39: 2060-2062 (1990)
41. Hollander D. The intestinal permeability barrier: A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 27:721-6 (1992)
42. Gardiner KR, Anderson NH, Rowlands BJ, Barbul A: Colitis and colonic mucosal barrier dysfunction. Gut 37:530-5 (1995)
43. Ingram LT, Coates T, Aden J, Higgens C, Baebner R, Boxer L: Metabolic, membrane and functional responses of human polymorphonuclear leukocytes to platelet activating factor. Blood 59:1259-66 (1982) (Pubitemid 12074856)
44. Sharon P, Stenson WF: Enhanced synthesis of leukotriene B 4 by colonic mucosa in inflammatory bowel disease.Gastroenterology 86:453-60 (1984) (Pubitemid 14154655)
45. Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M:Active oxygen species generated by monocytes and polymorphonuclear leukocytes in Crohn's disease. Dig Dis Sci 33:951-5(1988)
46. Alican I, Kubes P: A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 270:225-37(1996)
47. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF: Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111:871-85 (1996) (Pubitemid 26327590)
48. Whittle BJ: Nitric oxide in gastrointestinal physiology and pathology. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York: Raven 267-94(1995)
49. Roediger WE, Lawson MJ, Nance SH, Radcliffe BC: Detectable colonic nitrite levels in inflammatory bowel disease - mucosal or bacterial malfunction? Digestion 35:199-204 (1986) (Pubitemid 17196481)
50. Kimura H, Hokari R, Miura S, Shigematsu T, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H: Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis.Gut 42:180-7 (1998) (Pubitemid 28212172)
51. Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SG, Pena AS: Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 30:784-8 (1995)
52. Tauber AI, Babior BM: Neutrophil oxygen reduction: the enzymes and the products. Adv Free Rad Biol Med 1: 265-307 (1985) (Pubitemid 16111630)
53. Winterbourn CC: Myeloperoxidase as an effective inhibitor of hydroxyl radical production. Implications for the oxidative reactions of neutrophils. J Clin Invest 78: 545-550 (1986) (Pubitemid 16074093)
54. Britigan BE, Coffman TJ, Buettner GR: Spin trapping evidence for the lack of significant hydroxyl radical production during the respiration burst of human phagocytes using a spin adduct resistant to superoxidemediate destruction. J Biol Chem 265:2650-6 (1990)
55. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320: 365-376 (1989) (Pubitemid 19106873)
56. Thomas EL, Grisham MB, Jefferson MM: Myeloperoxidase- dependent effect of amines on functions of isolated neutrophils. J Clin Invest 72:441-454 (1983) (Pubitemid 13051304)
57. Moummi C, Gullikson GW, Grisham MB, Gaginella TS: Differential effects of reactive oxygen metabolites on neurally stimulated and nonstimulated guinea pig ileum. J Pharmacol Exp Ther 265:266 271 (1991)
58. Rumley AG, Paterson JR: Analytical aspects of antioxidants and free radical activity in clinical biochemistry. Ann Clin Biochem 35: 181-200 (1998) (Pubitemid 28127548)
59. Chiarpotto E, Scavazza A, Leonarduzzi G, Camandola S, Biasi F, Teggia PM, Garavoglia M, Robecchi A, Roncari A, Poli G: Oxidative damage and transforming growth factor beta 1 in pretumoral and tumoral lesions of human intestine. Free Rad Biol Med 22: 889-94 (1997) (Pubitemid 27058353)
60. Sedghi S, Keshavarzian A, Klamut M, Eiznhamer D, Zarling EJ: Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation. Am J Gastroenterol 89: 2217-21 (1994) (Pubitemid 24363673)
61. Chevion M, Berenshtein E, Stadtman ER: Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Rad Res 33: S99-108 (2000)
62. Ischiropoulos H, Al-Mehdi AB: Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 364: 279-82 (1995)
63. R. D'Inca, R. Cardin, L. Benazzato, I. Angriman, D. Martines, G.C. Sturniolo: Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm. Bowel Dis 10:23-27 (2004) (Pubitemid 38072441)
64. F. Fogt, A.O. Vortmeyer, H. Goldmann, T.J. Giordano, M.J. Merino, Z. Zhuang: Comparison of genetic alterations in colonic adenoma and ulcerative colitis associated dysplasia and carcinoma, Hum. Pathol 29:131- 136 (1998) (Pubitemid 28099507)
65. Y. Yuan, F. Li, M.W. Dewhirst, C.Y. Li,: Tumor necrosis factor alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res 66: 11565- 11570 (2006) (Pubitemid 46094163)
66. R.A. Risques, P.S. Rabinovitch, T.A. Brentnall: Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr. Opin. Gastroenterol 22: 382-90 (2006) (Pubitemid 44090193)